| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2006 | EP1349836B1 Tetracyclic derivatives as spla2 inhibitors |
| 06/14/2006 | EP1349550B1 Substituted-4-quinolones for the treatment of autoimmune diseases |
| 06/14/2006 | EP1347778B1 Behavior chemotherapy |
| 06/14/2006 | EP1343746B1 Use of carboxylic acid compound having cyclopropane ring as medicament |
| 06/14/2006 | EP1341770B1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/14/2006 | EP1341759B1 3-substituted oxindole beta 3 agonists |
| 06/14/2006 | EP1341548A4 METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY $g(b)-AMYLOID PEPTIDES |
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1313457B1 Transdermal therapeutic system for releasing venlafaxine |
| 06/14/2006 | EP1309703B1 Kallikrein gene |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | EP1309315B1 Rapidly disintegrating oral formulation of valdecoxib |
| 06/14/2006 | EP1286667B1 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases |
| 06/14/2006 | EP1272148B1 Compositions for metabolic protection and repair of lips |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | EP1267851B1 Compositions comprising carotenoids and use thereof for preventing hormone induced adverse effects |
| 06/14/2006 | EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate) |
| 06/14/2006 | EP1261338B1 Compositions and methods for treatment of epilepsy |
| 06/14/2006 | EP1255558B1 Anti-april antibodies and hybridoma cells |
| 06/14/2006 | EP1248606B1 Use of fumaric acid derivatives for treating mitochondrial diseases |
| 06/14/2006 | EP1248595A4 Multi-step drug dosage forms |
| 06/14/2006 | EP1214925B1 Chemical peeling agent |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1210100B1 Method of treating traumatic brain using non-steroidal anti-inflammatory drugs |
| 06/14/2006 | EP1175205B1 Solid dispersion comprising ritonavir, fenofibrate or griseofulvin |
| 06/14/2006 | EP1173186B1 Use of tagatose to enhance key blood factors |
| 06/14/2006 | EP1165085B1 Phthalazine derivatives for treating inflammatory diseases |
| 06/14/2006 | EP1157704B1 Spla2 inhibitors for the treatment of ischaemic reperfusion injury |
| 06/14/2006 | EP1143963B1 Multiparticulate bisoprolol formulation |
| 06/14/2006 | EP1135115B1 Use of sibutramine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 06/14/2006 | EP1102742B1 Compounds and compositions for delivering active agents |
| 06/14/2006 | EP1097210B1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 06/14/2006 | EP1071468B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 06/14/2006 | EP1033129B1 Antimicrobials for treating peptic ulcer |
| 06/14/2006 | EP1032696B1 Vector for tissue-specific replication and gene expression |
| 06/14/2006 | EP1024709B1 Use of an organ-specific nutritional composition |
| 06/14/2006 | EP1017675B1 Highly lipophilic camptothecin derivatives |
| 06/14/2006 | EP0966283B1 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells |
| 06/14/2006 | EP0964869B1 Methods and compositions for the treatment of neoplastic diseases |
| 06/14/2006 | EP0934593B1 Electrically conductive adhesive hydrogels |
| 06/14/2006 | EP0928135B1 System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 06/14/2006 | EP0879035B1 Bismuth-containing compositions in topical dosage forms |
| 06/14/2006 | DE3844992B4 Acetyl:cholinesterase inhibitor compsns. for trans:dermal application - contg. substd. phenyl carbamate, e.g. new (s)-3-(1-di:methylamino-e thyl)phenyl N-ethyl-N-methyl-carbamate |
| 06/14/2006 | DE102005055385A1 Arzneimittel zur hygienischen Applikation im Ohr Medicines for hygienic application in the ear |
| 06/14/2006 | DE102004059880A1 Stabiles, hormonhaltiges (Zwischen-)Produkt Stable, containing hormones (intermediate) product |
| 06/14/2006 | DE102004059792A1 Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform A multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for preparing the drug form |
| 06/14/2006 | DE102004059674A1 Transdermal delivery system to treat movement disease and post-operative illness comprises scopolamine and a matrix comprising styrene-butadiene-copolymer-bonding adhesive |
| 06/14/2006 | DE102004059521A1 Solid composition used as acetyl cholinesterase inhibitor comprises perindopril, microcrystalline cellulose, inorganic carbonate and other components |
| 06/14/2006 | DE102004059219A1 Pyrazindicarbonsäureamide und ihre Verwendung Pyrazindicarbonsäureamide and their use |
| 06/14/2006 | DE102004058449A1 Tetrahydropyranderivate Tetrahydropyran |
| 06/14/2006 | CN1788018A Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS 06 of pseudomonas aeruginosa |
| 06/14/2006 | CN1788013A New 3-decladinosyl 9a-n -carbamoyl and 9a-n -thiocarbamoyl derivatives of 9-deox-9-dihydro-9a-aza-9a-homoerythromycin a |
| 06/14/2006 | CN1788009A Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 06/14/2006 | CN1788007A Crystal of benzimidazole derivative and process for producing the same |
| 06/14/2006 | CN1788006A Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 06/14/2006 | CN1788004A Polymorphis of valsartan |
| 06/14/2006 | CN1788002A Biaryl substituted triazoles as sodium channnel blockers |
| 06/14/2006 | CN1788001A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787999A Histone deacetylase inhibitors |
| 06/14/2006 | CN1787997A 4-arylsulphonylpiperidine derivatives for antagonism of the 5-HT2A receptor |
| 06/14/2006 | CN1787995A Alpha, omega-dicarboximide derivatives as useful uro-selective alpha1alpha adrenoceptor blockers |
| 06/14/2006 | CN1787993A S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1787840A Drug for treating hemophilia and method of treating hemophilia using the same |
| 06/14/2006 | CN1787834A One or several enzyme-containing compounds, dietetic food products and drugs produced from said compounds and the use therefor for medical purposes |
| 06/14/2006 | CN1787833A Pharmaceutical preparations comprising acid-stabilised insulin |
| 06/14/2006 | CN1787832A Method of treating inflammtory disease associated with bone destruction |
| 06/14/2006 | CN1787826A Supplement food for low blood glucose recovery |
| 06/14/2006 | CN1787825A External patch containing estrogen and/or progestogen |
| 06/14/2006 | CN1787824A External preparation for improving coital function |
| 06/14/2006 | CN1787823A 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/14/2006 | CN1787822A Compouds and uses thereof in modulating amyloid beta |
| 06/14/2006 | CN1787821A A method of treating an anxiety disorder |
| 06/14/2006 | CN1787820A Composition for improving cognition and memory |
| 06/14/2006 | CN1787819A Method of treating atherosclerosis, dyslipidemias and related conditions and medical composition |
| 06/14/2006 | CN1787818A Amino cyclobutylamide modulators of chemokine receptor activity |
| 06/14/2006 | CN1787817A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/14/2006 | CN1787816A Method and kit for regulation of microvascular tone |
| 06/14/2006 | CN1787815A Use of phthalide derivatives for the treatment and prevention of diabetes mellitus |
| 06/14/2006 | CN1787814A Method for augmenting the antitumor activity of anti-cancer agents |
| 06/14/2006 | CN1787813A Treatment and/or prevention of non-viral epithelial damage |
| 06/14/2006 | CN1787810A Cladribine formulations for improved oral and transmucosal delivery |
| 06/14/2006 | CN1787809A Oral formulations of cladribine |
| 06/14/2006 | CN1787808A Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles |
| 06/14/2006 | CN1787807A Method of preparing a formulation containing a microdosed active component |
| 06/14/2006 | CN1787806A Topical treatment of skin conditions |
| 06/14/2006 | CN1787750A Hot liquid fiber product |
| 06/14/2006 | CN1786042A Catalyzing synthesis of polylactide and polyserine morphodilone from carboxylic acid creatinine guanidine |
| 06/14/2006 | CN1786034A Preparation method of umbellate pore fungus polysaccharide sulphate |
| 06/14/2006 | CN1786003A Sulfur, nitrogen heterocyclic naphacyl imine cell compounds and its application in tumour cell |
| 06/14/2006 | CN1786001A Composition stable blood porphrin derivative, its preparation method and injection agent |
| 06/14/2006 | CN1786000A Sodium salt of Entecavir, its preparation method and pharmaceutical application |
| 06/14/2006 | CN1785997A Pharmaceutical compound, its preparation method and application in making medicine |
| 06/14/2006 | CN1785996A Antifungus compound, its preparation method and application |
| 06/14/2006 | CN1785995A 2,5-disubstituted-1,3-dioxygen cycle compound, their synthesis and application as PKC inhibiter |
| 06/14/2006 | CN1785991A Anti inflammatory detoxication luteolin kind new medicine and its preparation method |
| 06/14/2006 | CN1785988A Saflor yellow pigment rich in saflor yellow pigment B, its preparation method and use |
| 06/14/2006 | CN1785985A Demethyl sodium cartharidate medicinal compound and its preparation method and application |
| 06/14/2006 | CN1785982A New benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |